Article info

PDF

The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis

Authors

  • Oliver M Fisher Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Sarah J Lord Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia NHMRC Clinical Trials Centre University of Sydney, Sydney, New South Wales, Australia Department of Epidemiology and Medical Statistics, School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Dan Falkenback Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia Department of Surgery, Lund University Hospital (Skåne University Hospital) and Lund University, Lund, Sweden PubMed articlesGoogle scholar articles
  • Nicholas J Clemons Cancer Biology and Surgical Oncology Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Guy D Eslick The Whiteley-Martin Research Centre, Discipline of Surgery, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Reginald V Lord Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia Department of Surgery, School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Oliver M Fisher, Gastroesophageal Cancer Research Group, St Vincent's Centre for Applied Medical Research, 405 Liverpool Street, Sydney NSW 2010, Australia; ofisher{at}gmx.ch
View Full Text

Citation

Fisher OM, Lord SJ, Falkenback D, et al
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis

Publication history

  • Received 12 October 2015
  • Revised 23 November 2015
  • Accepted 4 December 2015
  • Published in print 1 March 2017.
  • Published online 15 February 2017.
  • Published first 5 January 2016.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.